[{"AccountsPayableCurrentAndNoncurrent_0_Q2_USD":23869000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5137000.0,"PaymentsToAcquireInvestments_2_Q2_USD":765888000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-5503000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2244000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1428000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-158000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":81584000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":145000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4626000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":38705000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":44483000.0,"OperatingIncomeLoss_2_Q2_USD":-296607000.0,"OperatingIncomeLoss_1_Q2_USD":-164186000.0,"OperatingExpenses_2_Q2_USD":296607000.0,"OperatingExpenses_1_Q2_USD":164186000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NetIncomeLoss_2_Q2_USD":-302110000.0,"NetIncomeLoss_1_Q2_USD":-166430000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-203783000.0,"OtherAssetsNoncurrent_0_Q2_USD":17709000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-418767000.0,"PrepaidExpenseCurrent_0_Q2_USD":9802000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":16494000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51128048.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51472901.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-6682000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1214000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1214000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_Q2_USD":16494000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":6609000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":537032.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":224129.0,"StockholdersEquity_0_Q2_USD":1128920000.0,"ShareBasedCompensation_2_Q2_USD":52691000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"Revenues_2_Q2_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1432348000.0,"RestrictedCashNoncurrent_0_Q2_USD":600000.0,"RestrictedCash_0_Q2_USD":620000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":238646000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":134575000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":12243000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":16500000.0,"ProceedsFromStockOptionsExercised_1_Q2_USD":6600000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":352258000.0,"Revenues_1_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":51128048.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":17708000.0,"LongTermInvestments_0_Q2_USD":8947000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":7605811.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-604842000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":281340000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":280720000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":280720000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":915789000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":915708000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":86000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":167000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AssetsFairValueDisclosure_0_Q2_USD":1205456000.0,"Assets_0_Q2_USD":1355697000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10941237.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":10543650.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":52691000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":27969000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":52691000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":27969000.0,"AdditionalPaidInCapital_0_Q2_USD":2551615000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":9601000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":91997000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":91997000.0,"AssetsCurrent_0_Q2_USD":1278093000.0,"MarketableSecuritiesCurrent_0_Q2_USD":915789000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockSharesOutstanding_0_Q2_shares":51608944.0,"LiabilitiesCurrent_0_Q2_USD":180866000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1355697000.0,"Liabilities_0_Q2_USD":226777000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":49701000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":915789000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-2225000.0,"InterestReceivableCurrent_0_Q2_USD":2123000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":8550000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":68047000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":2578000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":108858000.0,"CommonStockSharesIssued_0_Q2_shares":51608944.0,"GeneralAndAdministrativeExpense_2_Q2_USD":57961000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12233000.0,"EarningsPerShareDiluted_1_Q2_USD":-3.23,"EarningsPerShareDiluted_2_Q2_USD":-5.91,"EarningsPerShareBasic_2_Q2_USD":-5.91,"EarningsPerShareBasic_1_Q2_USD":-3.23,"Depreciation_2_Q2_USD":705000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":65000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-302268000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-166285000.0,"CommonStockValue_0_Q2_USD":52000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":29611000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51472901.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]